← Back to Search

Prostaglandin Analog

Bimatoprost Topical Solution for Headache Disorders

Phase 2
Waitlist Available
Research Sponsored by Manistee Partners
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of migraines based on International Classification of Headache Disorders (ICHD) II criteria and experiencing headaches for 4 or more days per month.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

The study is to assess the effectiveness of topically applied bimatoprost in reducing migraine headache frequency, severity, and duration. It will also assess the effect of topical bimatoprost on quality of life.

Eligible Conditions
  • Headache Disorders
  • Migraine

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reduction in Headache Frequency
Secondary outcome measures
Duration of Headaches
Intensity of Headaches
Migraine Disability Assessment Scale (MIDAS)--Quality of Life

Side effects data

From 2016 Phase 4 trial • 379 Patients • NCT02017327
1%
breast neoplasm
1%
intervetebral disk protrusion
1%
prostate cancer
100%
80%
60%
40%
20%
0%
Study treatment Arm
Monoprost
Lumigan 0.01%
Lumigan 0.03% Unit Dose

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Bimatoprost Topical SolutionExperimental Treatment1 Intervention
0.03% bimatoprost topical solution applied daily to the nail bed of fingers on one hand for 12 weeks
Group II: ControlPlacebo Group1 Intervention
Saline placebo topically applied daily to the nail be of fingers on one hand for 12 weeks

Find a Location

Who is running the clinical trial?

Manistee PartnersLead Sponsor
Robert L Bratzler, PhDStudy ChairManistee Partners

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Topical Bimatoprost in the Treatment of Migraine
2018. "Topical Bimatoprost in the Treatment of Migraine". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03419715.
All > Migraine > Latisse
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top